Jonna Lorenz

HIV-positive to HIV-positive kidney and liver transplantation showed no evidence of HIV superinfection, a new study in The Lancet HIV found.

The human IgG1 monoclonal antibody TY014 showed promise as a possible prophylaxis or post-exposure treatment for yellow fever in a Phase 1 trial in Singapore.

A committee of experts convened by the National Academies of Sciences, Engineering, and Medicine recently offered recommendations for local school districts to guide decisions about school reopening during the pandemic.

The live attenuated intranasal pertussis vaccine, BPZE1, may protect against disease and asymptomatic infection and transmission.

Disease severity was higher among people of color hospitalized with COVID-19, according to a review of chest X-rays.

Shingles vaccination rates have risen from 6.7% in 2008 to 34.5% in 2018 among American adults 60 and older.

A common combination of probiotics showed no benefits for reducing antibiotic administration in older adults in care homes, according to a study led by Oxford University investigators.

Asymptomatic and presymptomatic cases of COVID-19 create challenges for identifying and combating the spread of the virus in detention facilities.

Skilled nursing facilities are facing an unprecedented crisis as deaths rise amid the COVID-19 pandemic while admissions and patient census decline, a new study shows.

Ebola virus disease definitions from the World Health Organization definitions could be improved by including contact history and intense fatigue as a key symptom and excluding fever, a new study found.

This therapy is associated with lower disease-related costs after treatment, but the costs of other conditions may outweigh total cost reductions over time.

Hospitalized patients with unverified penicillin allergies may unnecessarily face greater risk of adverse drug events when given broader spectrum alternative antibiotics, according to a new study.

Despite guidelines discouraging use of anti-pseudomonal β-lactams and fluoroquinolones for community-acquired complicated intra-abdominal infection, about 75% of lower-risk patients are receiving such treatments, a new study found.

Treatment of tuberculosis in adults with HIV can reduce mortality, but systematic treatment may go a step too far, increasing risk of adverse events compared with test-guided treatment, a new study found.

Deaths associated with pneumoconiosis fell 40% from 1999 to 2018, with the greatest decrease among coal workers cases, according to a new report.

A recent review of electronic health data revealed a 42% drop in emergency department visits during 4 weeks of the pandemic.

Broad-spectrum antimicrobial therapy is common among critically ill patients, but few undergo antimicrobial de-escalation, a new study found.

Health officials are urging parents to adhere to recommended vaccination schedules amid the COVID-19 pandemic, which has led to a drop in vaccination coverage.

Household members of patients with drug-resistant tuberculosis often have resistant infections, but differences with respect to specific drugs are common.

A review of 61 clinical trials suggests that acute uncomplicated cystitis in adult women could be treated with shorter duration of antibiotics in some cases.

A dosage of 250 mg twice daily for 10 days was confirmed for the next phase of trials after achieving initial and sustained cure in 100% of patients.

The novel drug combines a fourth-generation cephalosporin with a novel extended-spectrum β-lactamase inhibitor.

Oral ibrexafungerp could cut hospital stays for patients with invasive candidiasis infections.

Study explores the antiviral mechanisms of C19orf66, an interferon-induced inhibitor.

Barriers to recommended vaccine coverage for low-income American adults include disparity in Medicaid programs and low reimbursement amounts, a new study found.

Investigators detailed a promising new approach to fighting malaria with an antibody that targets a specific malaria protein, triggering the pathogen to self-destruct.

Investigators in Italy found ceftolozane/tazobactam to be an effective treatment for some patients with severe ESBL-E infections.

Vaccination rates remain below recommended levels in many areas.

The CDC lists Brucellosis among the top 8 concerning zoonotic diseases in the United States.

More than 2 million ambulatory clinic encounters and 100,000 hospitalizations annually are due to the disease.